Brief: Amniotics Q3 EBITDA Loss Widens To SEK 15.3 Million
Nov 10 (Reuters) - Amniotics AB (publ) AMNI.ST :
* AMNIOTICS PUBLISHES ITS REPORT FOR THE THIRD QUARTER OF
2022
* Q3 EBITDA LOSS SEK 15.3 MILLION VERSUS LOSS SEK 9.8
MILLION YEAR
AGO
Source text for Eikon: ID:nMFN6tNGZX
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan